🔴 Alzamend Neuro is trading 7.36% down in after-hours trading amid likely broad risk-off pressure

Alzamend Neuro is trading 7.36% down now at $1.51 in after-hours trading, as broader risk-off sentiment likely pressured the stock.

• The stock closed August 20, 2026, at $1.63.
• AL001 Phase 1/2A neuroimaging findings were accepted for a Neuroscience 2026 poster presentation, supporting the regular-session gain but not explaining the after-hours decline.
• The announcement was reported August 20, 2026; Nasdaq fell 1.16% and S&P 500 fell 0.71%.